<SEC-DOCUMENT>0001104659-25-095926.txt : 20251002
<SEC-HEADER>0001104659-25-095926.hdr.sgml : 20251002
<ACCEPTANCE-DATETIME>20251002110249
ACCESSION NUMBER:		0001104659-25-095926
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251002
DATE AS OF CHANGE:		20251002

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Solana Co
		CENTRAL INDEX KEY:			0001610853
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				364787690
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89397
		FILM NUMBER:		251367380

	BUSINESS ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940
		BUSINESS PHONE:		215-944-6100

	MAIL ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20180525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC
		DATE OF NAME CHANGE:	20180517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20140613

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fusion Summer Ltd
		CENTRAL INDEX KEY:			0002087954
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		WALKERS CORPORATE LIMITED
		STREET 2:		190 ELGIN AVENUE
		CITY:			GEORGE TOWN
		NON US STATE TERRITORY:  	GRAND CAYMAN
		PROVINCE COUNTRY:   	E9
		ZIP:			KY1-9001
		BUSINESS PHONE:		85239598000

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		WALKERS CORPORATE LIMITED
		STREET 2:		190 ELGIN AVENUE
		CITY:			GEORGE TOWN
		NON US STATE TERRITORY:  	GRAND CAYMAN
		PROVINCE COUNTRY:   	E9
		ZIP:			KY1-9001
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Fusion Summer Ltd -->
          <cik>0002087954</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Common Stock, $0.001 par value per share</securitiesClassTitle>
      <dateOfEvent>09/18/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001610853</issuerCIK>
        <issuerCUSIP>42328V876</issuerCUSIP>
        <issuerName>Helius Medical Technologies, Inc.</issuerName>
        <address>
          <com:street1>642 Newtown Yardley Road, Suite 100</com:street1>
          <com:city>NEWTOWN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>18940</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>CHEE Choon Wee</personName>
          <personPhoneNum>(215) 944-6100</personPhoneNum>
          <personAddress>
            <com:street1>C/O HELIUS MEDICAL TECHNOLOGIES, INC.</com:street1>
            <com:street2>642 NEWTOWN YARDLEY RD #100</com:street2>
            <com:city>NEWTOWN</com:city>
            <com:stateOrCountry>PA</com:stateOrCountry>
            <com:zipCode>18940</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002087954</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Fusion Summer Limited</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>6830402.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>6830402.00</sharedDispositivePower>
        <aggregateAmountOwned>6830402.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.0</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Note to Rows 8, 10 and 11: Consists of 6,830,402 shares of Class A Common Stock (the "Common Stock") held directly by Fusion Summer Limited and acquired pursuant to the Securities Purchase Agreement as further described in Item 3 and Item 6.

Note to Row 13: The percentage of beneficial ownership is calculated based on 40,295,612 shares outstanding as of September 24, 2025 (which number was provided by the Issuer to the Reporting Persons).</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0002086036</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>CHEE Choon Wee</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>N8</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>6830402.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>6830402.00</sharedDispositivePower>
        <aggregateAmountOwned>6830402.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>Note to Rows 8, 10 and 11:  Consists of (6,830,402 shares of Class A Common Stock (the "Common Stock") beneficially owned by Mr. CHEE, who is the ultimate controlling person of Fusion Summer Limited.

Note to Row 13: The percentage of beneficial ownership is calculated based on 40,295,612 shares outstanding as of September 24, 2025 (which number was provided by the Issuer to the Reporting Persons).</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Class A Common Stock, $0.001 par value per share</securityTitle>
        <issuerName>Helius Medical Technologies, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>642 Newtown Yardley Road, Suite 100</com:street1>
          <com:city>NEWTOWN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>18940</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13D is being filed jointly by (i) Fusion Summer Limited, a Cayman Islands exempted company ("Fusion Summer") and (ii) Mr. CHEE Choon Wee (collectively, the "Reporting Persons"). An agreement among the Reporting Persons to file this Schedule 13D jointly is attached as Exhibit 99.1.</filingPersonName>
        <principalBusinessAddress>The business address of Fusion Summer and Mr. CHEE is C/O HELIUS MEDICAL TECHNOLOGIES, INC. 642 NEWTOWN YARDLEY RD #100, NEWTOWN, PA, 18940.</principalBusinessAddress>
        <principalJob>The principal business of Fusion Summer is to serve as an investment holding company.

Mr. CHEE's present principal occupation is serving as the Executive Chairman of the Issuer's board of directors.</principalJob>
        <hasBeenConvicted>During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, none of the Reporting Persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>Fusion Summer is an exempted company organized under the laws of the Cayman Islands.

Mr. CHEE is a Malaysian citizen.</citizenship>
      </item2>
      <item3>
        <fundsSource>The information set forth in Item 4 is incorporated by reference in its entirety into this Item 3.

On September 15, 2025, the Issuer entered into a Securities Purchase Agreement (the "Purchase Agreement") with Fusion Summer, pursuant to which Fusion Summer acquired 6,830,402 shares of Common Stock for an aggregate purchase price of approximately $47.0 million. The closing of this transaction occurred on September 18, 2025.

The funds used by Fusion Summer to purchase these securities were its personal funds.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The Reporting Persons acquired the securities of the Issuer for investment purposes. The Reporting Persons intend to continuously review their investment in the Issuer.

The transactions reported herein were effected in connection with a private placement financing transaction by the Issuer (the "PIPE Transaction"). In connection with the PIPE Transaction, Mr. CHEE was appointed to serve as the Executive Chairman of the Issuer's board of directors (the "Board"), effective as of the closing of the transaction.

Depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, the outcome of the discussions referenced above, actions taken by the Board, price levels of the Common Stock, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate. These actions may include, without limitation: (i) acquiring additional shares of Common Stock and/or other equity, debt, notes, or other securities of the Issuer (collectively, "Securities"); (ii) disposing of any or all of their Securities; (iii) engaging in hedging or other transactions with respect to the Securities; and/or (iv) engaging in discussions with management, the Board, other stockholders of the Issuer and other relevant parties, or taking other actions to propose changes in the business, operations, governance or capitalization of the Issuer.

Except as set forth herein, the Reporting Persons have no present plans or proposals that relate to or that would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>The information contained on the cover pages to this Schedule 13D is incorporated by reference into this Item 5.</percentageOfClassSecurities>
        <numberOfShares>The information contained on the cover pages to this Schedule 13D is incorporated by reference into this Item 5. The aggregate number and percentage of the Common Stock beneficially owned by each Reporting Person are as follows:

Fusion Summer Limited

*   Amount beneficially owned: 6,830,402 shares
*   Percent of class: 17.0%
*   Sole power to vote or to direct the vote: 0
*   Shared power to vote or to direct the vote: 6,830,402
*   Sole power to dispose or to direct the disposition: 0
*   Shared power to dispose or to direct the disposition: 6,830,402

These shares consist of 6,830,402 shares of Common Stock held directly by Fusion Summer. Fusion Summer shares the power to vote and dispose of these securities with Mr. CHEE.

CHEE Choon Wee

*   Amount beneficially owned: 6,830,402 shares
*   Percent of class: 17.0%
*   Sole power to vote or to direct the vote: 0
*   Shared power to vote or to direct the vote: 6,830,402
*   Sole power to dispose or to direct the disposition: 0
*   Shared power to dispose or to direct the disposition: 6,830,402

These shares consist of 6,830,402 shares beneficially owned indirectly as Mr. CHEE is the ultimate controlling person of Fusion Summer. As the ultimate controlling person of Fusion Summer, Mr. CHEE may be deemed to share the power to vote and dispose of the securities held by Fusion Summer.

The percentages reported herein are calculated based on 40,295,612 shares of Common Stock outstanding as of September 24, 2025 (which information is provided by the Issuer to the Reporting Persons).</numberOfShares>
        <transactionDesc>Except for the acquisition of securities described in Item 3, none of the Reporting Persons have effected any transactions in the Common Stock during the past sixty days.</transactionDesc>
        <listOfShareholders>To the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Persons.</listOfShareholders>
        <date5PercentOwnership>Not applicable</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>The information set forth in Items 2, 3, 4, and 5 is incorporated by reference in its entirety into this Item 6.

Joint Filing Agreement

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is attached as Exhibit 99.1 hereto, pursuant to which the Reporting Persons have agreed to file this Schedule 13D and any amendments thereto jointly.

Securities Purchase Agreement

As described in Item 3, Fusion Summer is a party to the Purchase Agreement, pursuant to which it acquired the shares of Common Stock. A form of the Purchase Agreement is filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the SEC on September 15, 2025, and incorporated by reference as Exhibit 99.2 to this Schedule 13D.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 99.1 - Joint Filing Agreement, dated as of September 29, 2025, by and among the Reporting Persons

Exhibit 99.2 - Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K, filed with the SEC on September 15, 2025)

www.sec.gov/Archives/edgar/data/1610853/000110465925089774/tm2526070d1_ex10-1.htm</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Fusion Summer Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ CHEE Choon Wee</signature>
          <title>CHEE Choon Wee, Director</title>
          <date>10/02/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>CHEE Choon Wee</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ CHEE Choon Wee</signature>
          <title>CHEE Choon Wee, Individually</title>
          <date>10/02/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2527821d2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Joint
Filing Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Rule&nbsp;13d-1(k)&nbsp;promulgated
under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons
(as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments
thereto) with respect to the Class&nbsp;A Common Stock, $0.001 par value per share, of Helius Medical Technologies,&nbsp;Inc., a Delaware
corporation, and that this Agreement may be included as an exhibit to such joint filing. This Agreement may be executed in any number
of counterparts, all of which taken together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned hereby execute
this Agreement as of October 02, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FUSION SUMMER LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%">&nbsp;</TD>
<TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ CHEE Choon Wee</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>Name:</TD>
<TD>CHEE Choon Wee</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>Title:</TD>
<TD>Director</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CHEE Choon Wee</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
<TD STYLE="vertical-align: top">&nbsp;</TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom">/s/ CHEE Choon Wee</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
